Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Sequenta
3955
Sequenta
Technology
Biotechnology
is dedicated to improving patient care in diseases mediated by immune cells. Our ClonoSIGHT™ test for MRD in lymphoid cancers launched in 2013.
Suggest edits
Founded
2008
Raised
$41.5M
Follow us
Also headquartered in San Francisco
Twitter
Uber
Instagram
TikTok
Airbnb
Lyft
Fitbit
LinkedIn
Reddit
مجموعة الأدوات منصة شليله
Companies in the same industry
Milestone Scientific Inc.
HepaRegeniX
Scaled Biolabs
AxioMed, LLC
Adgero
GlucanBio
Comet Biorefining, Inc.
Pivotal bioVenture Partners
Hennepin Life Sciences
Benitec
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
20 Oct
2014
Venture capital
Celgene
Celgene Participates in New Round of Investment for Sequenta
businesswire
02 Jul
2013
$20,000,000
Venture capital (Series C)
Foresite Capital
01 Jan
2012
$8,460,000
Undisclosed funding
Index Ventures
,
Mohr Davidow Ventures
08 Dec
2010
$13,000,000
Venture capital (Series B)
Jacob Goldfield
